COMMUNIQUÉS West-GlobeNewswire

Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody
16/06/2026
IND submission for AVTX-010 planned for the first half of 2027 WAYNE, Pa., June 16, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing [...]
nCAP Medical Announces Publication of Positive RCT Results Demonstrating NeuroCuple® Provides Meaningful, Opioid-Sparing Pain Relief Immediately Following Total Knee Arthroplasty
16/06/2026
The study, published in the Journal of Arthroplasty, highlighted that the Company’s NeuroCuple® Nanotechnology Device achieved statistically significant reduction in opioid use, pain, and hospital length of stay, as [...]
Weston Family Foundation invests an additional $37 million to safeguard one of Canada’s most ecologically valuable and threatened ecosystems
16/06/2026
The conservation initiative brings together Indigenous communities, ranchers, and conservation organizations to protect Canada’s critical prairie grasslands TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- The Weston Family [...]
Breckenridge Brewery Launches a Colorado-Wide Soccer Celebration with Fan-First Activations
16/06/2026
With watch parties, foosball competitions, trivia, limited-release beer, and match-day specials, Breckenridge Brewery is creating tournament moments for fans across Colorado all summer long BRECKENRIDGE, Colo., June 16 [...]
VitalHub Announces Deployments of Referral Management Solutions
16/06/2026
TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that Novari Health, a VitalHub company, has executed agreements to implement wait list and [...]
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16/06/2026
WATERTOWN, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, [...]
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
16/06/2026
Potentially best-in-class IL-2 based treatment for autoimmune diseases by expanding and activating regulatory T cells Readout for dose-escalating clinical study for first two dose cohorts All participants in second dose [...]
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water
16/06/2026
Follows U.S. EPA's April 2026 decision to include microplastics as a priority contaminant group under the Safe Drinking Water Act's draft Contaminant Candidate List Company underscores relevance of advanced filtration [...]
Transactions in connection with share buy-back program
16/06/2026
Company announcement no. 21 - 26 16 June 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
À l’occasion du congrès HLTH Europe 2026, le King Faisal Specialist Hospital présente son écosystème d’IA appliquée en radiologie
16/06/2026
AMSTERDAM, 16 juin 2026 (GLOBE NEWSWIRE) -- Le professeur Ahmad AbuSalah, titulaire d’un doctorat, directeur du Digital Innovation Hub au King Faisal Specialist Hospital & Research Centre (KFSH), présente le modèle [...]
King Faisal Specialist Hospital Showcases Applied AI Ecosystem in Radiology at HLTH Europe 2026
16/06/2026
AMSTERDAM, June 16, 2026 (GLOBE NEWSWIRE) -- Professor Ahmad AbuSalah, PhD, Director of the Digital Innovation Hub at King Faisal Specialist Hospital & Research Centre (KFSH), is presenting the hospital's model for [...]
Aplagon Announces EUR 5 Million Financing to Broaden Phase 2 Trials of its APAC Therapy in Thrombo-Inflammatory Diseases
16/06/2026
Financing Supports Phase 2 Clinical Trial for Arteriovenous Fistula Maturation Failure in End Stage Kidney Disease HELSINKI, June 16, 2026 (GLOBE NEWSWIRE) -- Aplagon , a clinical-stage biotechnology company developing [...]
Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement
16/06/2026
REYKJAVIK, ICELAND (June 16, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients [...]
Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement
16/06/2026
REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar [...]
Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026
15/06/2026
-- Setmelanotide therapy achieved robust, sustained and clinically significant weight loss in patients with acquired HO at 2.5 years -- - - Bivamelagon therapy achieved progressive reductions in BMI and hunger measures [...]
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
15/06/2026
REYKJAVIK, ICELAND (June 15, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients [...]
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
15/06/2026
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology Mont-Saint-Guibert, Belgium – June 15, 2026, 10:05 pm CET / 04:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company [...]
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering
15/06/2026
Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibility Additional proceeds used to pay for the capped call with a premium of at least 75% and to repurchase up to $25 [...]
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
15/06/2026
REYKJAVIK, Iceland, June 15, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar [...]

Pages